Suppr超能文献

两家社区药房的续方同步计划评估

Evaluation of a refill synchronization program in two community pharmacies.

作者信息

Blackburn David F, Tran David, Quiring Courtney

出版信息

J Am Pharm Assoc (2003). 2016 Nov-Dec;56(6):656-659. doi: 10.1016/j.japh.2016.06.015. Epub 2016 Oct 5.

Abstract

OBJECTIVES

To describe medication adherence by the proportion of days covered before and after enrollment in a refill synchronization program.

METHODS

We conducted a retrospective analysis of medication adherence in 2 pharmacies offering a refill synchronization program. The study population consisted of individuals who received 2 or more medications from any of 15 predefined medication classes within 6 months of enrollment in the synchronization program. Medication adherence and refill consolidation were measured over 6 months before and after enrollment. Optimal adherence was defined as proportion of days covered ≥80%.

RESULTS

Among 109 patients who enrolled in the program between 2009 and 2014, 68 were included in a pre-post analysis of medication adherence. In the preenrollment period, optimal adherence was observed in 85% (217/254) of the medications taken by the 68 patients, increasing to 93% (237/254) in the postenrollment period (P <0.01). In addition, the percentage maintaining optimal adherence to all of their medications increased significantly from 60% (n = 41) to 83% (n = 57; P <0.01).

CONCLUSION

Among a small group of patients who voluntarily participated in refill synchronization programs, high levels of medication adherence were observed in the preenrollment period. These results combined with previous studies suggest that voluntary participants of these programs are at a low risk for nonadherence; therefore, current estimates of benefit from refill synchronization programs may be overestimated.

摘要

目的

通过在重新配药同步计划登记前后的覆盖天数比例来描述药物依从性。

方法

我们对两家提供重新配药同步计划的药房的药物依从性进行了回顾性分析。研究人群包括在同步计划登记后6个月内从15种预定义药物类别中的任何一种接受两种或更多药物治疗的个体。在登记前后的6个月内测量药物依从性和重新配药合并情况。最佳依从性定义为覆盖天数比例≥80%。

结果

在2009年至2014年期间登记参加该计划的109名患者中,68名被纳入药物依从性的前后分析。在登记前阶段,68名患者服用的药物中有85%(217/254)观察到最佳依从性,在登记后阶段增加到93%(237/254)(P<0.01)。此外,对所有药物保持最佳依从性的百分比从60%(n = 41)显著增加到83%(n = 57;P<0.01)。

结论

在一小群自愿参加重新配药同步计划的患者中,登记前阶段观察到较高水平的药物依从性。这些结果与先前的研究表明,这些计划的自愿参与者不依从的风险较低;因此,目前对重新配药同步计划益处的估计可能被高估了。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验